Skip to content
  • Home
  • About
  • Services
  • News
  • Careers
  • Contact
  • Home
  • About
  • Services
  • News
  • Careers
  • Contact

Day: July 24, 2024

Inadequate Sponsor Oversight and TMF: MHRA Infringement Notice

Posted on July 24, 2024 by Carol Wiley

In the realm of clinical trials, maintaining comprehensive and accurate documentation is not just a regulatory requirement but a cornerstone of ethical and effective research. Recently, the Medicines and Healthcare products Regulatory Agency (MHRA) issued an Infringement Notice to Celixir for significant deficiencies in trial oversight, including a glaring lack of sponsor Trial Master File […]

Read more

Filed under: Uncategorized

Recent Posts

  • Records vs. Documents in Clinical Trials
  • When Drugs Fail: Is it Bad Science—or Just Bad Research?
  • Change Management in Clinical Research
  • Why Innovation in Clinical Compliance Can’t Wait
  • ICH E6(R3) Sponsor Oversight

Recent Comments

  • rutrum on 4 Reasons Why GCP Compliance Is Important
  • etiam on Insights from the 2024 Veeva R&D and Quality Summit
  • lyonnais on Welcome Aaron Grant as Head of Innovation
  • modishly on Employee Spotlight – Ralf Brooks
  • shiatzus on The Recent FDA Draft Guidance on Processes & Practices Applicable to a BIMO Inspection

Archives

  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024

Categories

  • Uncategorized

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • About
  • Services
  • Contact
  • Careers
  • Privacy Notice
  • About
  • Services
  • Contact
  • Careers
  • Privacy Notice
215-343-4484
info@justintimegcp.com
© 2025 Just In Time GCP - All Rights Reserved
Twitter Linkedin